Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited (SOLARA) is a micro-cap Healthcare company valued at ₹3,347 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Solara Active Pharma Sciences Limited last traded at ₹650, modestly up 0.18% on the day.

Recent developments

On 2026-06-30, the company reported a net loss of ₹7 crore for the fiscal year ending March 2026, reversing a prior year profit. The latest quarter ended June 2026 showed a net profit of ₹16 crore, up from ₹11 crore in the same quarter a year earlier.

Financial performance

The company's annual revenue rose 6.6% to ₹1,369 crore, but net profit swung to a loss of ₹7 crore from a profit of ₹1 crore. The latest quarter saw revenue jump 19.6% to ₹382 crore and net profit surge 48.3% to ₹16 crore, indicating improved performance in the recent period.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.71 times book value.

Things to watch

The company reported a net loss of ₹7 crore for the latest fiscal year, compared to a profit of ₹1 crore in the prior year. Net profit margin fell to -0.5% from 0.1% in the previous year. The stock is 7.6% below its 52-week high, and promoter shares pledged account for 37.11% of their holding.

Where it stands

The company ended the latest fiscal year with a net loss of ₹7 crore, but the latest quarter showed a net profit of ₹16 crore, up 48.3% from the same quarter a year earlier. The stock is 7.6% below its 52-week high, and promoter shares pledged account for 37.11% of their holding.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.